NovaBay Pharmaceuticals, Inc.
NBY
$1.03
$0.4371.67%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 611.58% | 364.45% | -85.29% | -77.65% | -82.99% |
| Total Receivables | -90.68% | -57.49% | -42.79% | -23.14% | -79.15% |
| Inventory | -33.29% | -- | 52.69% | -86.11% | -81.42% |
| Prepaid Expenses | -32.92% | -57.56% | -24.61% | 12.80% | -24.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 54.26% | 50.00% | -94.34% | 52.63% | -52.53% |
| Total Current Assets | 171.42% | 151.68% | -72.95% | -72.25% | -79.91% |
|
|
|||||
| Total Current Assets | 171.42% | 151.68% | -72.95% | -72.25% | -79.91% |
| Net Property, Plant & Equipment | -73.49% | -72.46% | -27.11% | -32.04% | -31.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.63% | 0.42% | -3.42% | -1.20% | -4.03% |
| Total Assets | 76.08% | 84.28% | -62.11% | -69.83% | -75.48% |
|
|
|||||
| Total Accounts Payable | -51.09% | -28.38% | -31.24% | -58.18% | -16.61% |
| Total Accrued Expenses | 44.66% | 25.14% | -34.22% | -52.12% | -44.14% |
| Short-term Debt | -84.05% | -91.66% | -50.31% | -95.98% | -41.27% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.07% | 7.47% | 8.15% | -19.59% | -19.75% |
| Total Finance Division Other Current Liabilities | -66.11% | 24.78% | -30.09% | -27.93% | -61.08% |
| Total Other Current Liabilities | -66.11% | 24.78% | -30.09% | -27.93% | -61.08% |
| Total Current Liabilities | -40.61% | -21.84% | -33.54% | -56.60% | -40.49% |
|
|
|||||
| Total Current Liabilities | -40.61% | -21.84% | -33.54% | -56.60% | -40.49% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -84.05% | -91.66% | -50.31% | -95.98% | -41.27% |
| Capital Leases | -43.99% | -38.71% | -36.01% | -34.00% | -32.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -41.30% | -28.71% | -37.90% | -51.76% | -38.99% |
|
|
|||||
| Common Stock & APIC | 1.42% | 2.73% | 4.03% | 7.36% | 5.31% |
| Retained Earnings | 1.29% | 1.49% | -4.92% | -10.00% | -9.82% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 780.42% | 564.98% | -109.90% | -78.93% | -109.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -99.60% | -99.69% | -99.70% | -99.72% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -99.60% | -99.69% | -99.70% | -99.72% |
|
|
|||||
| Total Common Equity | 780.42% | 564.98% | -109.90% | -78.93% | -109.68% |
| Total Preferred Equity | 0.00% | -99.60% | -99.69% | -99.70% | -99.72% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 788.01% | 3,754.38% | -103.89% | -84.77% | -107.21% |
|
|
|||||